Publications — Tagawa Lab

Publications

Articles are linked to publisher’s websites (open in a new tab). In press articles will be linked to preprint servers such as bioRxiv. Select publications have dedicated pages with more detail.

https://www.embopress.org/doi/full/10.1038/s44319-023-00051-z
More detail
Ramaswami, R., T. Tagawa, G. Mahesh, A. Serquina, V. Koparde, K. Lurain, S. Dremel, X. Li, A. Mungale, A. Beran, Z.W. Ohler, L. Bassel, A. Warner, R. Mangusan, A. Widell, I. Ekwede, L.T. Krug, T.S. Uldrick, R. Yarchoan, and J.M. Ziegelbauer. In press. Transcriptional landscape of Kaposi sarcoma tumors identifies unique immunologic signatures and key determinants of angiogenesis. J. Transl. Med. doi: 10.1101/2022.03.18.484923.
Tagawa, T., D. Oh, S. Dremel, G. Mahesh, V.N. Koparde, G. Duncan, T. Andresson, and J.M. Ziegelbauer. 2023. A virus-induced circular RNA maintains latent infection of Kaposi’s sarcoma herpesvirus. Proc National Acad Sci. 120:e2212864120. doi:10.1073/pnas.2212864120.
Click here for more detail.
Albanese, M., T. Tagawa, and W. Hammerschmidt. 2022. Strategies of Epstein-Barr virus to evade innate antiviral immunity of its human host. Front Microbiol. 13:955603. doi:10.3389/fmicb.2022.955603.
IDETA, Y., T. TAGAWA, Y. HAYASHI, J. BABA, K. TAKAHASHI, K. MITSUDO, and K. SAKURAI. 2021. Transcriptomic Profiling Predicts Multiple Pathways and Molecules Associated With the Metastatic Phenotype of Oral Cancer Cells. Cancer Genom - Proteom. 18:17–27. doi:10.21873/cgp.20238.
Bouvet, M., S. Voigt, T. Tagawa, M. Albanese, Y.-F.A. Chen, Y. Chen, D.N. Fachko, D. Pich, C. Göbel, R.L. Skalsky, and W. Hammerschmidt. 2021. Multiple Viral microRNAs Regulate Interferon Release and Signaling Early during Infection with Epstein-Barr Virus. Mbio. 12:e03440-20. doi:10.1128/mbio.03440-20.
Serquiña, A.K.P., T. Tagawa, D. Oh, G. Mahesh, and J.M. Ziegelbauer. 2021. 25-Hydroxycholesterol Inhibits Kaposi’s Sarcoma Herpesvirus and Epstein-Barr Virus Infections and Activates Inflammatory Cytokine Responses. Mbio. 12:e02907-21. doi:10.1128/mbio.02907-21.
Albanese, M., Y.-F.A. Chen, C. Hüls, K. Gärtner, T. Tagawa, E. Mejias-Perez, O.T. Keppler, C. Göbel, R. Zeidler, M. Shein, A.K. Schütz, and W. Hammerschmidt. 2021. MicroRNAs are minor constituents of extracellular vesicles that are rarely delivered to target cells. Plos Genet. 17:e1009951. doi:10.1371/journal.10.1371/journal.pgen.1009951.
Tagawa, T., V.N. Kopardé, and J.M. Ziegelbauer. 2021. Identifying and characterizing virus-encoded circular RNAs. Methods. 196:129–137. doi:10.1016/j.ymeth.2021.03.004.
Click here for more detail
Tagawa, T., D. Oh, J. Santos, S. Dremel, G. Mahesh, T.S. Uldrick, R. Yarchoan, V.N. Kopardé, and J.M. Ziegelbauer. 2021. Characterizing Expression and Regulation of Gamma-Herpesviral Circular RNAs. Front Microbiol. 12:670542. doi:10.3389/fmicb.2021.670542.
Click here for more detail
Tagawa, T., A. Serquiña, I. Kook, and J. Ziegelbauer. 2020. Viral non-coding RNAs: Stealth strategies in the tug-of-war between humans and herpesviruses. Semin Cell Dev Biol. 111:135–147. doi:10.1016/j.semcdb.2020.06.015.
Schaeffner, M., P. Mrozek-Gorska, A. Buschle, A. Woellmer, T. Tagawa, F.M. Cernilogar, G. Schotta, N. Krietenstein, C. Lieleg, P. Korber, and W. Hammerschmidt. 2019. BZLF1 interacts with chromatin remodelers promoting escape from latent infections with EBV. Life Sci Alliance. 2:e201800108. doi:10.26508/lsa.201800108.
Danisch, S., C. Slabik, A. Cornelius, M. Albanese, T. Tagawa, Y.-F.A. Chen, N. Krönke, B. Eiz-Vesper, S. Lienenklaus, A. Bleich, S.J. Theobald, A. Schneider, A. Ganser, C. von Kaisenberg, R. Zeidler, W. Hammerschmidt, F. Feuerhake, and R. Stripecke. 2018. Spatiotemporally Skewed Activation of Programmed Cell Death Receptor 1–Positive T Cells after Epstein-Barr Virus Infection and Tumor Development in Long-Term Fully Humanized Mice. Am J Pathology. 189:521–539. doi:10.1016/j.ajpath.2018.11.014.
Davis, D.A., P. Shrestha, A.I. Aisabor, A. Stream, V. Galli, C.A. Pise-Masison, T. Tagawa, J.M. Ziegelbauer, G. Franchini, and R. Yarchoan. 2018. Pomalidomide increases immune surface marker expression and immune recognition of oncovirus-infected cells. Oncoimmunology. 8:1–16. doi:10.1080/2162402x.2018.1546544.
Tagawa, T., S. Gao, V.N. Koparde, M. Gonzalez, J.L. Spouge, A.P. Serquiña, K. Lurain, R. Ramaswami, T.S. Uldrick, R. Yarchoan, and J.M. Ziegelbauer. 2018. Discovery of Kaposi’s sarcoma herpesvirus-encoded circular RNAs and a human antiviral circular RNA. Proc National Acad Sci. 115:201816183. doi:10.1073/pnas.1816183115.
Click here for more detail
Albanese, M., T. Tagawa, A. Buschle, and W. Hammerschmidt. 2017. MicroRNAs of Epstein-Barr Virus Control Innate and Adaptive Antiviral Immunity. J Virol. 91:e01667-16. doi:10.1128/jvi.01667-16.
Albanese, M., T. Tagawa, M. Bouvet, L. Maliqi, D. Lutter, J. Hoser, M. Hastreiter, M. Hayes, B. Sugden, L. Martin, A. Moosmann, and W. Hammerschmidt. 2016. Epstein–Barr virus microRNAs reduce immune surveillance by virus-specific CD8+ T cells. Proc National Acad Sci. 113:E6467–E6475. doi:10.1073/pnas.1605884113.
Tagawa, T., M. Albanese, M. Bouvet, A. Moosmann, J. Mautner, V. Heissmeyer, C. Zielinski, D. Lutter, J. Hoser, M. Hastreiter, M. Hayes, B. Sugden, and W. Hammerschmidt. 2016. Epstein-Barr viral miRNAs inhibit antiviral CD4+ T cell responses targeting IL-12 and peptide processing. J Exp Med. 213:2065–2080. doi:10.1084/jem.20160248.